Methazolamide

In the US, Methazolamide (methazolamide systemic) is a member of the drug class carbonic anhydrase inhibitors and is used to treat Glaucoma.

US matches:

• Methazolamide

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

S01EC05

CAS registry number (Chemical Abstracts Service)

0000554-57-4

Chemical Formula

C5-H8-N4-O3-S2

Molecular Weight

236

Therapeutic Categories

Carbonic anhydrase inhibitor

Glaucoma treatment

Ophthalmic agent

Chemical Name

Acetamide, N-[5-(aminosulfonyl)-3-methyl-1,3,4-thiadiazol-2(3H)-ylidene]-

Foreign Names

• Methazolamidum (Latin)
• Methazolamid (German)
• Méthazolamide (French)
• Metazolamida (Spanish)

Generic Names

• Methazolamide (OS: BAN, JAN)
• Méthazolamide (OS: DCF)
• Methazolamide (PH: USP 32)

Brand Names

• Apo-Methazolamide
  Apotex, Canada



• Methazolamide
  Mikart, United States; Sandoz, United States; Teva USA, United States



• Methazolamide-Teva
  Teva, Israel

International Drug Name Search

Glossary

BAN	British Approved Name
DCF	Dénomination Commune Française
JAN	Japanese Accepted Name
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.